These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25042130)
1. Impulse control disorders in frontotemporal dementia: spectrum of symptoms and response to treatment. Pompanin S; Jelcic N; Cecchin D; Cagnin A Gen Hosp Psychiatry; 2014; 36(6):760.e5-7. PubMed ID: 25042130 [TBL] [Abstract][Full Text] [Related]
2. Topiramate for the treatment of kleptomania: a case series and review of the literature. Dannon PN Clin Neuropharmacol; 2003; 26(1):1-4. PubMed ID: 12567156 [TBL] [Abstract][Full Text] [Related]
3. Topiramate for abnormal eating behaviour in frontotemporal dementia. Singam C; Walterfang M; Mocellin R; Evans A; Velakoulis D Behav Neurol; 2013 Jan; 27(3):285-6. PubMed ID: 23548883 [TBL] [Abstract][Full Text] [Related]
4. Topiramate augmentation in a patient with obsessive-compulsive disorder. Van Ameringen M; Patterson B J Psychiatry Neurosci; 2015 Sep; 40(5):E31-2. PubMed ID: 26290064 [No Abstract] [Full Text] [Related]
5. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Dannon PN; Lowengrub K; Gonopolski Y; Musin E; Kotler M Clin Neuropharmacol; 2005; 28(1):6-10. PubMed ID: 15711432 [TBL] [Abstract][Full Text] [Related]
6. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. Goodman WK; Ward H; Kablinger A; Murphy T J Clin Psychiatry; 1997; 58 Suppl 5():32-49. PubMed ID: 9184625 [TBL] [Abstract][Full Text] [Related]
8. Resolution of Pathological Skin Picking With Fluvoxamine in a 74-Year-Old Dementia Patient. Hafeez ZH Prim Care Companion CNS Disord; 2016; 18(1):. PubMed ID: 27247839 [No Abstract] [Full Text] [Related]
10. Use of Topiramate in Skin-Picking Disorder: A Pilot Study. Jafferany M; Osuagwu FC Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28129492 [TBL] [Abstract][Full Text] [Related]
11. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series. Van Ameringen M; Mancini C; Patterson B; Bennett M Depress Anxiety; 2006; 23(1):1-5. PubMed ID: 16178009 [TBL] [Abstract][Full Text] [Related]
12. The behavioral variant of frontotemporal dementia: An analysis of the literature and a case report. Birkhoff JM; Garberi C; Re L Int J Law Psychiatry; 2016; 47():157-63. PubMed ID: 27143117 [TBL] [Abstract][Full Text] [Related]
13. Clomipramine in the treatment of compulsive behavior in frontotemporal dementia: a case series. Furlan JC; Henri-Bhargava A; Freedman M Alzheimer Dis Assoc Disord; 2014; 28(1):95-8. PubMed ID: 22892646 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of topiramate in children and adolescent with problems in impulse control: preliminary results]. Dolengevich Segal H; Rodríguez Salgado B; Conejo Garcia A; San Sebastian Cabases J Actas Esp Psiquiatr; 2006; 34(4):280-2. PubMed ID: 16823690 [TBL] [Abstract][Full Text] [Related]
16. Lamotrigine use in patients with binge eating and purging, significant affect dysregulation, and poor impulse control. Trunko ME; Schwartz TA; Marzola E; Klein AS; Kaye WH Int J Eat Disord; 2014 Apr; 47(3):329-34. PubMed ID: 24343841 [TBL] [Abstract][Full Text] [Related]
17. Correlated patterns of neuropsychological and behavioral symptoms in frontal variant of Alzheimer disease and behavioral variant frontotemporal dementia: a comparative case study. Li P; Zhou YY; Lu D; Wang Y; Zhang HH Neurol Sci; 2016 May; 37(5):797-803. PubMed ID: 26573591 [TBL] [Abstract][Full Text] [Related]
18. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder. Hollander E; Dell'Osso B Int Clin Psychopharmacol; 2006 May; 21(3):189-91. PubMed ID: 16528143 [TBL] [Abstract][Full Text] [Related]
19. Treatment of binge-eating disorder with topiramate: a clinical case series. Shapira NA; Goldsmith TD; McElroy SL J Clin Psychiatry; 2000 May; 61(5):368-72. PubMed ID: 10847312 [TBL] [Abstract][Full Text] [Related]
20. Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study. Emamzadehfard S; Kamaloo A; Paydary K; Ahmadipour A; Zeinoddini A; Ghaleiha A; Mohammadinejad P; Zeinoddini A; Akhondzadeh S Psychiatry Clin Neurosci; 2016 Aug; 70(8):332-41. PubMed ID: 27106362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]